A prospective study focused on the role of ivermectin in the fight against SARS-CoV-2 published as examined by the companion American Journal of Therapeutics.
Consistent with the abstract of the study, Drs. Tess Lawrie (MBBCh, PhD), a medical evidence EXPERTS, and his team “Evaluated the efficacy of ivermectin treatment in reducing mortality, secondary outcome, and chemoprophylaxis, among individuals with, or at high risk of, COVID-19 infection.”
** IVERMECTIN NEWS ** We cannot give enough weight to the worldwide importance of this newly published paper.
It provides the highest possible systematic review and meta-analysis for #ivermectin with no doubt whatsoever that the global adoption of IVM should be implemented immediately. https://t.co/W3ePN3EKbH
– Frontline Covid-19 Critical Care (@ Covid19Critical) June 20, 2021
Ivermectin, an anti-parasitic drug with both antiviral and anti-inflammatory properties, is used by doctors around the world as both a treatment and a prophylactic for COVID-19, the disease caused by SARS-CoV -2.
While governments and public health officials have tried to find solutions to the disease to work with it, some doctors and scientists have gone to rely on, though also repeated, medications — a custom that is not uncommon when face a new or unexpected situation.
Despite the safety and available anecdotal evidence, critics of drug use are quick to point out the lack of studies reviewed by colleagues using ivermectin to treat viral infection and consequent disease.
In response to criticisms and consequent attacks on ivermectin use by Big Tech, Big Pharma, and public health organizations around the world, Drs. Lawrie and his team have bibliographic databases until April 25 this year. The authors “Filtered for studies, obtained data, and assessed the risk of bias” before conducting a meta-analysis that resulted in the inclusion of 24 randomized control trials involving 3,406 participants.
The study authors conclude that “Significant reduction in mortality with COVID-19 is possible with the use of ivermectin.” Safe and effective medicine “It’s likely to have a significant impact on SARS-CoV-2 pandemic around the world. ”
Dr. told. Lawrie TestSite:
“We are happy to have a product of many months of hard work that has finally been published! And what a great team of writers – it is an honor to work with people with such high integrity, who maintain a spirit of hope and optimism despite all the difficulties we face. Thanks for not giving! Now the authorities have all the evidence they need to immediately approve ivermectin.. ”
The study also reflects what has been observed in other studies “From Bangladesh and India to Peru and Argentina; from Israel and Nigeria to ICON studies in South Florida and public health initiatives using ivermectin from Mexico City to Uttar Pradesh, India,” reports TestSite News.
Although increased censorship with ivermectin across Big Tech social media platforms and search engines, the response to the social media study has been largely positive and continues to grow.
NAPublikar LANG! ???? Specific ivermectin testing – it works – now let’s use it! https://t.co/svG8tcBHXg
– BIRD Group (@BIRDGroupUK) June 19, 2021
Extremely rigorous and conservative analysis of 15 separate trials concluded that Ivermectin reduced Covid mortality. This information should lead to many trials, at this time in the courts.https://t.co/QsNi4Dy4su
– Chris Martenson (@chrismartenson) June 20, 2021
This meta-analysis of the effectiveness of Ivermectin is currently reviewed and published only. Evidence of prophylactic effectiveness is paramount. https://t.co/FKT3zETmtw
– Bret Weinstein (@BretWeinstein) June 20, 2021
Bryant-Lawrie’s standard Cochrane (= highest) review and meta-analysis of Ivermectin versus Covid-19, which is now reviewed and also published, concludes that the evidence justifies global adoption.https://t.co/7gSGUKp6mY pic.twitter.com/DKN3UiT391
– Covid19Crusher (@ Covid19Crusher) June 19, 2021
No one can say no #ivermectin which has a 62% reduction in the risk of death. 86% reduction in risk of infection. Reviewed by partner. Published in the American Journal of Therapeutics. Hat to Dr Tess Lawrie and team! @BIRDGroupUK @ Covid19Critical @afriforum https://t.co/bYCYIq6OVE
– Barend Petrus Uys (@ bpuys6) June 19, 2021
Awareness of the effectiveness of ivermectin and its adoption by physicians around the world to successfully treat COVID-19 continues to accelerate.